Internal Medicine, Endocrinology, Diabetes, & Metabolism · Ponce, PR
NPI
1386646917
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2431 Blvd Luis A Ferre Ste 303
Ponce, PR, 00717
Phone (787) 844-5177
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,458
27 services
Medicare patients, 2024
12
Average age 76
Drug cost, 2024
$2.1M
13,719 prescriptions
Company payments, 2025
$194
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose A Montalvo-Figueroa was code 99213 (office e&m - established), 23 times for 11 patients. In total Jose A Montalvo-Figueroa billed 27 services in 2 codes, and Medicare paid $1,458.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 23 | 11 | $59.66 | $1,372 |
By year: 2022 $1,585 for 25 services; 2023 $1,711 for 30 services; 2024 $1,458 for 27 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose A Montalvo-Figueroa prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 2,735 prescriptions and refills. In total Jose A Montalvo-Figueroa wrote 13,719 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 2,735 | 3,411 | 407 | $153K |
| Atorvastatin Calcium Generic | 950 | 1,273 | 177 | $7,158 |
| Metformin Hcl Generic | 484 | 664 | 108 | $2,721 |
| Amlodipine Besylate Generic | 454 | 557 | 78 | $1,666 |
| Farxiga Dapagliflozin Propanediol | 433 | 495 | 97 | $289K |
| Rosuvastatin Calcium Generic | 413 | 579 | 73 | $4,034 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 370 | 503 | 69 | $42K |
| Glimepiride Generic | 314 | 427 | 61 | $2,656 |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 290 | 352 | 50 | $32K |
| Ezetimibe Generic | 287 | 353 | 55 | $3,262 |
| Trulicity Dulaglutide | 276 | 293 | 35 | $292K |
| Jardiance Empagliflozin | 259 | 301 | 63 | $185K |
| Hydrochlorothiazide Generic | 258 | 337 | 50 | $1,328 |
| Levothyroxine Sodium Generic | 257 | 333 | 58 | $2,243 |
| Lisinopril Generic | 235 | 325 | 47 | $1,181 |
Brand drugs: 6,467 claims; generic drugs: 6,318 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose A Montalvo-Figueroa $194 ($194 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $115.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.